APT Pharma Limited has acquired Universal Pharmaceutical Labs
APT Pharma Limited, a subsidiary of Jacobson Pharma Group, has acquired the entire shareholding in Universal Pharmaceutical Laboratories Ltd, a subsidiary of Li & Fung Group, for US$10.8 million.
APT Pharma Limited is a leading pharmaceutical manufacturer in Hong Kong, with manufacturing plants in both Hong Kong and Zhongshan.
Universal Pharmaceutical Laboratories Ltd manufactures and distributes private labeled pharmaceuticals, imported pharmaceuticals, health food and nutritional supplements, and various health and beauty care products in Hong Kong.
Li & Fung Group operates three core businesses: it designs, develops and sources consumer products for retailers worldwide; the group operates extensive logistics and distribution networks serving major brands globally. Another core business is retailing, where the company offers convenience stores and bakeries through Convenience Retail Asia Limited, luxury menswear through Trinity Limited, and toys and children's products through Toys (Labuan) Holding Limited.
Oaklins' team in Hong Kong advised the shareholders of APT Pharma Limited in this transaction.
Talk to the deal team
Oaklins Tonghai Capital
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
Leading manufacturer of luxury beds SCHRAMM acquired by Spanish Flex Bedding Group
The shareholders of SCHRAMM Werkstätten GmbH have sold the company to Flex Equipos De Descanso, S.A.Learn more
Ro&Zo has completed a first-ever external funding round
Ro&Zo has raised funds to drive its direct-to-consumer business by raising awareness of its brand, develop its operations capability and scale the business in the UK. Pembroke, the highly regarded consumer focused VCT, has invested over US$1.7million in the business.Learn more